Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Howarth

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
ERJ Open Research|November 12, 2025
Mepolizumab in patients with severe asthma and blood eosinophil counts between 150 and 300 cells per µL: benefits at two yearsGiorgio W Canonica, Diego Bagnasco, Jason K Lee, et al.
The Journal of Allergy and Clinical Immunology|March 6, 2017
Susceptibility to influenza virus infection of bronchial biopsies in asthmaBen Nicholas, Sarah Dudley, Kamran Tariq, et al.
ERJ Open Research|September 23, 2020
Response to mepolizumab treatment is sustained across 4-weekly dosing periodsIan D Pavord, Eugene R Bleecker, Roland Buhl, et al.
The Journal of Allergy and Clinical Immunology|February 22, 2020
Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapyPeter Howarth, Geoffrey Chupp, Linda M Nelsen, et al.
Journal of Leukocyte Biology|September 9, 2025
Spatial profiling reveals complex cellular responses of anti-IL5 treatment with mepolizumab in eosinophilic chronic rhinosinusitis with nasal polyposisNicholas P West, Sarah M Williams, James Sinclair, et al.
The New England Journal of Medicine|July 18, 2003
Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthmaAshley Woodcock, Louise Forster, Edward Matthews, et al.
American Journal of Respiratory and Critical Care Medicine|June 24, 2026
Reply to Siddiqui et al., Godbout et al., and to Chang and MaoGeoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch, et al.
Allergy|May 16, 2022
Nontypeable Haemophilus influenzae infection of pulmonary macrophages drives neutrophilic inflammation in severe asthmaJodie Ackland, Clair Barber, Ashley Heinson, et al.
The Journal of Allergy and Clinical Immunology|June 29, 2012
Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthmaClaus Bachert, Kristel van Steen, Nan Zhang, et al.
International Forum of Allergy & Rhinology|July 3, 2026
Differences in Biologic Clinical Trials for Chronic Rhinosinusitis With Nasal Polyps-Are We Comparing Apples With Oranges?Marjolein Cornet, Peter W Hellings, Martin Desrosiers, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
ERJ Open Research|November 12, 2025
Mepolizumab in patients with severe asthma and blood eosinophil counts between 150 and 300 cells per µL: benefits at two yearsGiorgio W Canonica, Diego Bagnasco, Jason K Lee, et al.
The Journal of Allergy and Clinical Immunology|March 6, 2017
Susceptibility to influenza virus infection of bronchial biopsies in asthmaBen Nicholas, Sarah Dudley, Kamran Tariq, et al.
ERJ Open Research|September 23, 2020
Response to mepolizumab treatment is sustained across 4-weekly dosing periodsIan D Pavord, Eugene R Bleecker, Roland Buhl, et al.
The Journal of Allergy and Clinical Immunology|February 22, 2020
Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapyPeter Howarth, Geoffrey Chupp, Linda M Nelsen, et al.
Journal of Leukocyte Biology|September 9, 2025
Spatial profiling reveals complex cellular responses of anti-IL5 treatment with mepolizumab in eosinophilic chronic rhinosinusitis with nasal polyposisNicholas P West, Sarah M Williams, James Sinclair, et al.
The New England Journal of Medicine|July 18, 2003
Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthmaAshley Woodcock, Louise Forster, Edward Matthews, et al.
American Journal of Respiratory and Critical Care Medicine|June 24, 2026
Reply to Siddiqui et al., Godbout et al., and to Chang and MaoGeoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch, et al.
Allergy|May 16, 2022
Nontypeable Haemophilus influenzae infection of pulmonary macrophages drives neutrophilic inflammation in severe asthmaJodie Ackland, Clair Barber, Ashley Heinson, et al.
The Journal of Allergy and Clinical Immunology|June 29, 2012
Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthmaClaus Bachert, Kristel van Steen, Nan Zhang, et al.
International Forum of Allergy & Rhinology|July 3, 2026
Differences in Biologic Clinical Trials for Chronic Rhinosinusitis With Nasal Polyps-Are We Comparing Apples With Oranges?Marjolein Cornet, Peter W Hellings, Martin Desrosiers, et al.
Pageof 11